Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-220,468
Closed -$12.6M 35
2023
Q2
$12.6M Sell
220,468
-186,452
-46% -$10.9M 1.68% 23
2023
Q1
$24.5M Buy
406,920
+76,356
+23% +$4.66M 3.06% 16
2022
Q4
$19.4M Sell
330,564
-24,249
-7% -$1.53M 2.86% 18
2022
Q3
$20.3M Sell
354,813
-120,488
-25% -$7.02M 3.72% 16
2022
Q2
$25.7M Sell
475,301
-52,864
-10% -$3.07M 4.86% 13
2022
Q1
$30.4M Buy
+528,165
New +$27M 5.2% 8

Other funds holding CTVA

M.D. Sass LLC's CTVA Position: Q3 2023 in Review

M.D. Sass LLC sold out of Corteva (CTVA) in Q3 2023, closing a stake of 220,468 shares — an estimated $12.6M sold.

M.D. Sass LLC first reported a position in CTVA in Q1 2022 and held it in 6 quarters. The position peaked at $30.4M in Q1 2022. 1,194 funds tracked by Wall St. Rank hold CTVA as of Q3 2023.

  • M.D. Sass LLC reported no remaining Corteva position as of Q3 2023 after selling out during the quarter.
  • M.D. Sass LLC sold 220,468 Corteva shares in Q3 2023, an estimated $12.6M.
  • M.D. Sass LLC first reported a position in Corteva in Q1 2022 and held it in 6 quarters.
  • M.D. Sass LLC's Corteva position peaked at $30.4M in Q1 2022.
  • 1,194 funds tracked by Wall St. Rank held Corteva as of Q3 2023.

Based on M.D. Sass LLC's 13F filing for Q3 2023, filed 14 Nov 2023.